This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Amilyfe, LLC, University of Florida Research Foundation Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025-2026
Title: Xiaodong Xu: Innovator in Cystic Fibrosis Treatment
Introduction
Xiaodong Xu is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of medical science, particularly in the treatment of cystic fibrosis. His innovative work focuses on amino acid compositions that enhance the functionality of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.
Latest Patents
Xiaodong Xu holds a patent for "Amino acid compositions and methods for treating cystic fibrosis." This patent describes amino acid compositions that are effective in increasing the translocation of the CFTR protein from the cytoplasm to the plasma membrane, especially in epithelial cells. The methods outlined in the patent aim to increase the concentration of CFTR in the plasma membrane, thereby enhancing chloride ion transport and water transport. These advancements are crucial for treating cystic fibrosis in individuals with mutations in the CFTR protein.
Career Highlights
Throughout his career, Xiaodong Xu has been associated with reputable organizations such as the University of Florida Research Foundation Inc and Amilyfe, LLC. His work in these institutions has allowed him to further his research and develop innovative solutions for cystic fibrosis.
Collaborations
Xiaodong Xu has collaborated with esteemed colleagues, including Sadasivan Vidyasagar and Astrid Grosche. These partnerships have contributed to the advancement of his research and the development of effective treatments for cystic fibrosis.
Conclusion
Xiaodong Xu's contributions to the field of cystic fibrosis treatment through his innovative patent and collaborations highlight his dedication to improving patient outcomes. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile